Elevated Liver Damage Biomarkers in Long COVID: A Systematic Review and Meta-Analysis.

Abbas F. Almulla,Yanin Thipakorn,Yingqian Zhang,Michael Maes
DOI: https://doi.org/10.1101/2024.10.18.24315698
2024-10-22
Abstract:Background:Long COVID (LC) presents with complex pathophysiology,affecting multiple organs and producing a range of symptoms,from neuropsychiatric disturbances to multi-organ dysfunction.Liver damage has emerged as a notable feature,yet no systematic review or meta-analysis has comprehensively evaluated the biomarkers confirming liver injury in LC patients. Objective:The present study aims to examine blood-based biomarkers of liver damage in LC disease. Methods:A search of PubMed,Google Scholar, SciFinder,and SCOPUS identified 61 eligible studies,including 7172 participants,with 3404 LC patients and 3768 controls. Results:Our analysis identified a significant increase in the liver damage index among LC patients,with a moderate effect size (standardized mean difference,SMD = 0.553;confidence intervals; 95% CI: 0.305;0.760) compared to normal controls. Additionally,LC patients exhibited marked elevations in alanine aminotransferase(SMD = 0.615;95% CI:0.351;0.878), aspartate aminotransferase(SMD=0.352;95%CI:0.068;0.637), gamma-glutamyl transferase(SMD=0.969;95% CI:0.194;1.745), and lactate dehydrogenase (SMD = 0.666; 95% CI: 0.332;0.999) activities. Moreover, significant reductions were observed in total protein (SMD = -0.326; 95% CI: -0.631 to -0.021) and platelet count (SMD = -0.424; 95% CI: -0.756 to -0.091), alongside increases in prothrombin time (SMD = 0.633;95%CI:0.0771.189),ferritin(SMD=0.437;95% CI: 0.0690.805),Ddimer(SMD=0.359;95%CI:0.1440.573), and fibrinogen(SMD=1.063;95%CI:0.412;1.714). Conclusion:This study suggests that LC is associated with persistent liver damage and coagulopathy,highlighting the need to incorporate liver injury into treatment strategies to reduce potential risks.
What problem does this paper attempt to address?